These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29729689)

  • 61. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors.
    Stănescu AD; Nistor E; Sajin M; Stepan AE
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1129-36. PubMed ID: 25607395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
    Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
    Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.
    Ravegnini G; Mariño-Enriquez A; Slater J; Eilers G; Wang Y; Zhu M; Nucci MR; George S; Angelini S; Raut CP; Fletcher JA
    Mod Pathol; 2013 May; 26(5):743-9. PubMed ID: 23222489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.
    Paal E; Miettinen M
    Am J Surg Pathol; 2001 Nov; 25(11):1355-63. PubMed ID: 11684951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features.
    Borella F; Mancarella M; Preti M; Mariani L; Stura I; Sciarrone A; Bertschy G; Leuzzi B; Piovano E; Valabrega G; Turinetto M; Pino I; Castellano I; Bertero L; Cassoni P; Cosma S; Franchi D; Benedetto C
    Int J Gynecol Cancer; 2024 Feb; 34(2):244-250. PubMed ID: 38054268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 69. POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY.
    Tanabe Y; Hayashi T; Okada M; Aburatani H; Tonegawa S; Abiko K; Konishi I
    Georgian Med News; 2024 May; (350):42-48. PubMed ID: 39089269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series.
    Chapel DB; Nucci MR; Quade BJ; Parra-Herran C
    Am J Surg Pathol; 2022 Apr; 46(4):464-475. PubMed ID: 34419987
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patterns of Chromosomal Abnormalities that Can Improve Diagnosis of Uterine Smooth Muscle Tumors.
    Holzmann C; Markowski DN; VON Leffern I; Löning T; Bullerdiek J
    Anticancer Res; 2015 Dec; 35(12):6445-56. PubMed ID: 26637855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. S100A6 expression in cutaneous smooth muscle neoplasms.
    Idriss MH; Elston DM
    APMIS; 2015 Oct; 123(10):832-6. PubMed ID: 26238340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.
    Rubisz P; Ciebiera M; Hirnle L; Zgliczyńska M; Łoziński T; Dzięgiel P; Kobierzycki C
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845657
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
    Lee JH; Ryu TY; Cho CH; Kim DK
    Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
    Markowski DN; Huhle S; Nimzyk R; Stenman G; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2013 Mar; 52(3):297-304. PubMed ID: 23225304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
    Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
    Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas.
    Huang LC; Ye JC; Hsieh CH; Chen LM; Lin TY; Hung YC; Chang WC
    Eur J Gynaecol Oncol; 2011; 32(5):496-9. PubMed ID: 22053660
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Progress in clinicopathologic study on uterine smooth muscle tumor of uncertain malignant potential].
    Deng ZJ; Guo LN
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):573-6. PubMed ID: 22169655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.